Tag Archives: Datamonitor

HIV Market Banking on Fixed-Dose Treatments

By George Koroneos | Published: July 8, 2010
The HIV markets are expected to grow for the next two years, but major patent expirations in the following years will have a huge impact on pharmaceutical sales by 2019, according to a new report by DataMonitor. Antiretroviral sales in 2009 were estimated at $11.8 billion. While that figure is forecast to hit $14.4 billion in [...]
Posted in R&D | Also tagged , , , , , , | Leave a comment

Authorized Generics Agreements to Increase

By Julian Upton | Published: July 29, 2009
Image by :: Wendy :: via Flickr The number of authorized generics (AG) agreements is likely to grow as pharma continues to converge with generics companies, a new report from Datamonitor claims. AG agreements are considered more ‘potent’ in the US market because market exclusivity is awarded to first-to-file generics companies, but detractors among the generics-producing [...]
Posted in Global, News, Regulatory | Also tagged , , , , , | 1 Comment